NCT07110389Enrolling by invitation
Effectiveness of a Tele-cardiac Rehabilitation (Tele-CR) Program
Effectiveness of a Mobile Application-Based Tele-cardiac Rehabilitation (Tele-CR) Program for Patients With Coronary Heart Disease (CHD): A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
This study represents the second phase of a three-year research project aimed at evaluating both the short- and long-term effects of a six-month tele-cardiac rehabilitation (tele-CR) program in patients with coronary heart disease (CHD). The primary outcomes include quality of life, self-efficacy, self-management, medication adherence, and mental health (anxiety and depression). In addition, comprehensive metabolic parameters will be assessed, including body mass index (BMI), systolic and diastolic blood pressure (SBP and DBP), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1C), and lipid profile markers such as triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), and low-density lipoprotein (LDL).
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- First submitted
- 25 Jul 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Chang Gung University of Science and Technology
- Diseases
- Coronary artery disease
- NCT number
- NCT07110389
What you commit to
- Study type: Interventional
- Planned participants: 126
- From 1 Oct 2025 to the primary completion date, 31 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planning to receive surgery (e.g., coronary artery bypass graft).
Other illness
- Level IV on the New York Heart Association Functional Classification.
- Have a history of severe arrhythmia (e.g., ventricular tachycardia, ventricular fibrillation, complete atrioventricular block).
- Combined with other serious heart diseases (e.g., congenital heart disease, cardiomyopathy).
- Mental disorders, end-stage renal disease and other systemic diseases diagnosed by a physician.
- Severe infection, injury, surgery (e.g., coronary artery bypass graft) or cancer treatment has occurred in the past three months.
- Physical activities are affected by neurological, respiratory, skeletal, or peripheral vascular diseases.
- Restricted use of the App due to sensory or cognitive impairment.
Lab values
- Left ventricular ejection fraction\<40%.
Other
- Already participated in other clinical trials.
Who the study is looking for
- The main diagnosis at admission of CHD.
- Age ≥20 years.
- Owns an iOS or Android smartphone and can use it.
- Conscious, clear and can communicate.
- Agrees to participate in the research after explanation and is willing to use the App.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung University of Science and Technology Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.